Likewise, our previous results [32] revealed that lowered SpO2 in the acute phase predicted lowered Gpx and increased NO production in long COVID patients and that elevated BT during acute COVID-19 predicted increased CRP and lowered antioxidant defenses, including zinc, in long COVID. The gene discussed is CRP; the disease is COVID-19.